2003 CGS Report on the UN Cloning Treaty Negotiations
By admin
| 11. 24. 2003
Human Cloning, the United Nations, and Beyond
On November 6, 2003, after two years of debate and no substantive
action, the United Nations voted to suspend until late 2005
any further consideration of a French-German proposal for an
international treaty to ban human cloning.
The vote in the Legal (Sixth) Committee of the UN General Assembly
was very close: 80 countries voted for the suspension, 79 wished
to continue negotiations, 15 formally abstained, and 17 were
not present.
What happened, and why? What are the implications for global
governance of the new human genetic technologies? What is likely
to happen next, and what can be done?
The Original Proposal
France and Germany initiated the cloning treaty process in
September 2001. They limited their proposed ban to reproductive
cloning because they recognized that a broader proposal - in
particular, one that also banned research cloning - would not
be able to attain the effective consensus required to successfully
conclude a treaty within the UN structure. They believed that
a treaty banning reproductive cloning would be a critically
important contribution in itself, and would establish a precedent
and structure...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
